aTyr Pharma Announces First Quarter 2018 Operating Results, Program Prioritization and Corporate Restructuring

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. KRG
2. SPY
3. ALAR
4. CCH:LN
5. META
6. BAJAJHFL:I
7. CCHGY
8. PRY:IM
9. PRYMY
10. FFAI

Go back to aTyr Pharma Announces First Quarter 2018 Operating Results, Program Prioritization and Corporate Restructuring

aTyr Pharma (LIFE) PT Lowered to $2 at BMO Capital

May 14, 2018 12:57 PM EDT

BMO Capital lowered its price target on aTyr Pharma (NASDAQ: LIFE) to $2.00 (from $4.00) while maintaining a Market Perform rating.

Analyst Matthew Luchini commented, "We remain Market Perform rated following discontinuation of the ORCA I/O program, and restructuring announcement. While the restructuring... More